baclofen has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Spinocerebellar ataxia type 1 (SCA1) is a progressive neurodegenerative disease caused by a gene defect, leading to movement disorder such as cerebellar ataxia." | 1.46 | Progressive impairment of cerebellar mGluR signalling and its therapeutic potential for cerebellar ataxia in spinocerebellar ataxia type 1 model mice. ( Hirai, H; Hosoi, N; Sato, Y; Shuvaev, AN; Yanagihara, D, 2017) |
| "Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a neurodegenerative disorder characterized by late-infantile onset spastic ataxia and other neurological features." | 1.37 | Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS): typical clinical and neuroimaging features in a Brazilian family. ( Abdala, N; Abdalla, C; Abrahão, A; Barsottini, OG; Braga-Neto, P; Pedroso, JL; Rivero, RL, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bushart, DD | 1 |
| Huang, H | 1 |
| Man, LJ | 1 |
| Morrison, LM | 1 |
| Shakkottai, VG | 1 |
| Berntsson, SG | 1 |
| Gauffin, H | 1 |
| Melberg, A | 1 |
| Holtz, A | 1 |
| Landtblom, AM | 1 |
| Shuvaev, AN | 1 |
| Hosoi, N | 1 |
| Sato, Y | 1 |
| Yanagihara, D | 1 |
| Hirai, H | 1 |
| Pedroso, JL | 1 |
| Braga-Neto, P | 1 |
| Abrahão, A | 1 |
| Rivero, RL | 1 |
| Abdalla, C | 1 |
| Abdala, N | 1 |
| Barsottini, OG | 1 |
4 other studies available for baclofen and Autosomal Dominant Cerebellar Ataxia, Type II
| Article | Year |
|---|---|
A Chlorzoxazone-Baclofen Combination Improves Cerebellar Impairment in Spinocerebellar Ataxia Type 1.
Topics: Animals; Ataxin-1; Baclofen; Calcium Channels, T-Type; Cerebellum; Chlorzoxazone; Disease Models, An | 2021 |
Inherited Ataxia and Intrathecal Baclofen for the Treatment of Spasticity and Painful Spasms.
Topics: Adult; Aged; Baclofen; Female; Friedreich Ataxia; Humans; Injections, Spinal; Male; Middle Aged; Mus | 2019 |
Progressive impairment of cerebellar mGluR signalling and its therapeutic potential for cerebellar ataxia in spinocerebellar ataxia type 1 model mice.
Topics: Animals; Baclofen; Biomechanical Phenomena; Calcium; Cerebellum; Disease Models, Animal; Excitatory | 2017 |
Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS): typical clinical and neuroimaging features in a Brazilian family.
Topics: Adult; Amitriptyline; Baclofen; Female; Humans; Magnetic Resonance Imaging; Male; Muscle Relaxants, | 2011 |